Cancer Vaccine
-
EnteroMix cancer vaccine: What Russia’s 100% efficacy claim really means
Health | Sep 07, 2025, 03:26 PM ISTRussia’s EnteroMix cancer vaccine is making headlines for “100% efficacy” in early trials. But experts caution that these are preliminary results from Phase I studies. Here’s what we know so far about EnteroMix, its promise, and why larger trials are crucial before real-world use.
-
Maharashtra government to provide free cancer vaccine for girls aged 0-14 across state
Maharashtra | Mar 01, 2025, 06:34 PM ISTThe Maharashtra government has decided to implement a free cancer vaccination programme to address the issue.
-
Cancer vaccine for women set to be launched in India within 5-6 months, know details
Health | Feb 18, 2025, 10:30 PM ISTIn a major development, Union Minister Prataprao Jadhav announced that cancer vaccines for women will be available soon. While there is still much research and testing needed, the use of cancer vaccines holds great promise in the fight against this devastating disease.
-
Russia claims it developed first cancer vaccine in big breakthrough, says 'will distribute for free'
Health | Dec 19, 2024, 06:49 PM ISTRussia has claimed that they have innovated a cancer vaccine and they will distribute it for free. However, they haven't been informed about the human trial yet. But with their recent claim, we can see a ray of hope for ending the cancer chapter.
-
Putin claims Russia is close to creating cancer vaccines I How will it impact India's medical burden
World | Feb 15, 2024, 10:13 AM ISTPharmaceutical companies Moderna and Merck & Co are developing an experimental cancer vaccine that a mid-stage study showed to cut the chance of recurrence or death from melanoma - the most deadly skin cancer - by half after three years of treatment.
-
Cancer vaccine developed to boost lifespan of patients
World | Oct 31, 2013, 07:35 AM ISTMoscow : Russian scientists have developed a vaccine for the treatment of cancer that can increase the patient's lifespan more than two-fold, ITAR-TASS reported Wednesday.The vaccine, developed at the Institute of Clinical Immunology in the